Inhibition of HCV RNA-dependent RNA polymerase activity by aqueous extract from Fructus Ligustri Lucidi

Virus Research

Volumn 128, Issue 1-2, 2007, Pages 9-17

  Kong, Lingbao ^a   Li, Shanshan ^a   Han, Xue ^a   Xiang, Zhonghua ^a   Fang, Xiaonan ^a   Li, Baozong ^a   Wang, Wei ^a   Zhong, Hong ^a   Gao, Jingrong ^a   Ye, Linbai ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cells; Fructus Ligustri Lucidi; Hepatitis C virus; Inhibit; NS5B

Indexed keywords

LIGUSTRUM LUCIDUM EXTRACT; PLANT EXTRACT; RNA POLYMERASE; VIRUS ENZYME; VIRUS RNA;

ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; CYTOTOXICITY; DNA TRANSFECTION; ENZYME ACTIVITY; ENZYME INHIBITION; FRUCTUS LIGUSTRI LUCIDI; FRUIT; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PLANT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; VIRUS REPLICATION; WESTERN BLOTTING;

CELL LINE, TUMOR; HEPACIVIRUS; HUMANS; LUCIFERASES; MEDICINE, CHINESE TRADITIONAL; PLANT EXTRACTS; RNA REPLICASE; RNA, VIRAL; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 34547769225     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.03.020     Document Type: Article

References (38)

1. Amoros M., Fauconnier B., and Girre R.L. In vitro antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against herpes simplex virus and poliovirus. Antiviral Res. 8 (1987) 13-25
2. Baker J.T., Borris R.P., Carte B., Cordell G.A., Soejarto D.D., Cragg G.M., Gupta M.P., Iwu M.M., Madulid D.R., and Tyler V.E. Natural product drug discovery and development: new perspectives on international collaboration. J. Nat. Prod. 58 (1995) 1325-1357
3. Bukh J. A critical role for the chimpanzee model in the study of hepatitis C. Hepatology 39 (2004) 1469-1475
4. Carroll S.S., Tomassini J.E., Bosserman M., Getty K., Stahlhut M.W., Eldrup A.B., Bhat B., Hall D., Simcoe A.L., LaFemina R., Rutkowski C.A., Wolanski B., Yang Z., Migliaccio G., De Francesco R., Kuo L.C., MacCoss M., and Olsen D.B. Inhibition of hepatitis C virus RNA replication by 2′-modified nucleoside analogs. J. Biol. Chem. 278 (2003) 11979-11984
5. Cavallaro L., Garcia G., Broussalis A., Martino V., Ferraro G., Coussio J., Torres R.D., and Campos R. Antiherpetic in vitro activity of Gamochaeta simplicicaulis. Phytother. Res. 9 (1995) 176-179
6. Chander G., Sulkowski M.S., Jenckes M.W., Torbenson M.S., Herlong H.F., Bass E.B., and Gebo K.A. Treatment of chronic hepatitis C: a systematic review. Hepatology 36 (2002) 135-144
7. Chang R.S., and Yeung H.W. Inhibition of growth of human immunodeficiency virus in vitro by crude extracts of Chinese medicinal herbs. Antiviral Res. 9 (1988) 163-175
8. Committee of National Pharmacopoeia. Pharmacopoeia of PR China vol. 1 (2000), Press of Chemical Industry, Beijing p. 34
9. Committee of Chinese Materia Medica. Chinese Materia Medica vol. 6 (1999), Shanghai Science and Technology Press, Shanghai pp. 183-189
10. De Francesco R., Tomei L., Altamura S., Summa V., and Migliaccio G. Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res. 58 (2003) 1-16
11. De Francesco G., and Migliaccio. Challenges and successes in developing new therapies for hepatitis C. Nature 436 (2005) 953-960
12. Forns X., Bukh J., and Purcell R.H. The challenge of developing a vaccine against hepatitis C virus. J. Hepatol. 37 (2002) 684-695
13. Friebe P., and Bartenschlager R. Genetic analysis of sequences in the 3′ nontranslated region of hepatitis C virus that are important for RNA replication. J. Virol. 76 (2002) 5326-5338
14. Friebe P., Lohmann V., Krieger N., and Bartenschlager R. Sequences in the 5′ nontranslated region of hepatitis C virus required for RNA replication. J. Virol. 75 (2001) 12047-12057
15. Goh P.Y., Tan Y.J., Lim S.P., Tan Y.H., Lim S.G., Fuller-Pace F., and Hong W. Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication. J. Virol. 78 (2004) 5288-5298
16. Hudson J.B. Plant photosensitizers with antiviral properties. Antiviral Res. 12 (1989) 55-74
17. Kim D.W., Gwack Y., Han J.H., and Choe J. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity. Biochem. Biophys. Res. Commun. 215 (1995) 160-166
18. Kim S.J., Kim J.H., Kim Y.G., Lim H.S., and Oh J.W. Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation. J. Biol. Chem. 279 (2004) 50031-50041
19. Kolykhalov A.A., Mihalik K., Feinstone S.M., and Rice C.M. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo. J. Virol. 74 (2000) 2046-2051
20. Kong L.B., Ye L.B., Ye L., Timani K.A., Zheng Y., Liao Q.J., Li B.Z., and Gao B. Establishment of stable HeLa cell lines expressing enzymatically active hepatitis C virus RNA polymerase. Arch. Virol. 151 (2006) 361-367
21. Kyono K., Miyashiro M., and Taguchi I. Human eukaryotic initiation factor 4AII associates with hepatitis C virus NS5B protein in vitro. Biochem. Biophys. Res. Commun. 292 (2002) 659-666
22. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
23. Lindenbach B.D., and Rice C.M. Unravelling hepatitis C virus replication from genome to function. Nature 436 (2005) 933-938
24. Murphy F.A., Fauquet C.M., Bishop D.H.L., Ghabrial S.A., Jarvis A.W., Martelli G.P., Mayo M.A., and Summers M.D. Classification and Nomenclature of Viruses: Sixth Report of the Internal Committee on Taxonomy of Viruses (1995), Springer-Verlag, Vienna, Austria pp. 424-426
25. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., and Ohta Y. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 6547-6549
26. Seeff L.B. Natural history of hepatitis C. Hepatology 26 (1997) 21-28
27. Shimakami T., Honda M., Kusakawa T., Murata T., Shimotohno K., Kaneko S., and Murakami S. Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon. J. Virol. 80 (2006) 3332-3340
28. Suzich J.A., Tamura J.K., Palmer-Hill F., Warrener P., Grakoui A., Rice C.M., Feinstone S.M., and Collett M.S. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J. Virol. 67 (1993) 6152-6158
29. Tabba H.D., Chang R.S., and Smith K.M. Isolation, purification, and partial characterization of prunellin, an anti-HIV component from aqueous extracts of Prunella vulgaris. Antiviral Res. 11 (1989) 263-273
30. Tu H., Gao L., Shi S.T., Taylor D.R., Yang T., Mircheff A.K., Wen Y., Gorbalenya A.E., Hwang S.B., and Lai M.M. Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology 263 (1999) 30-41
31. Venkateswaran P.S., Millman I., and Blumberg B.S. Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 274-278
32. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 (2005) 791-796
33. Yanagi M., St Claire M., Emerson S.U., Purcell R.H., and Bukh J. In vivo analysis of the 3′ untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 2291-2295
34. Yao X.J., Wainberg M.A., and Parniak M.A. Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgaris. Virology 187 (1992) 56-62
35. Ye L., Timani K.A., Ye L., Kong L., Yang X., Liao Q., and Wu J. Two cis-acting elements in negative RNA strand of hepatitis C virus involved in synthesis of positive RNA strand in vitro. Acta Virol. 49 (2005) 83-90
36. Yi M., and Lemon S.M. 3′ nontranslated RNA signals required for replication of hepatitis C virus RNA. J. Virol. 77 (2003) 3557-3568
37. Zhang X., Zhang H., Zheng C., Li C., Zhang X., and Xiong W. Extremely low frequency (ELF) pulsed-gradient magnetic fields inhibit malignant tumour growth at different biological levels. Cell Biol. Int. 26 (2002) 599-603
38. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 9294-9299